POAG puts pressure on the heart

Article

Patients with primary open-angle glaucoma (POAG) have a higher level of cardiovascular risk than in age-matched patients without glaucoma, according to a report published in a recent issue of Graefe's Archive for Clinical and Experimental Ophthalmology.

Patients with primary open-angle glaucoma (POAG) have a higher level of cardiovascular risk than in age-matched patients without glaucoma, according to a report published in a recent issue of Graefe's Archive for Clinical and Experimental Ophthalmology.

Nicola Orzalesi and colleagues from the OPTIME Study group, collected and analysed data from the medical history of 2,879 POAG patients and 973 age-matched controls, from 35 centres in Italy. Data relating to vascular risk factors were collected by means of a detailed questionnaire and all subjects underwent a complete ophthalmic examination with assessment of intraocular pressure (IOP), visual field, optic disc and systemic blood pressure. The European Society of Hypertension/European Society of Cardiology (ESH-ESC) guidelines were used to calculate the level of cardiovascular risk.

The POAG patients had significantly higher systolic and diastolic blood pressure, systolic perfusion pressure and IOP compared to the control group. However, diastolic perfusion pressure did not significantly differ between the groups. Myopia was more common in the POAG group (23% compared to 18%), as was a positive family history of glaucoma (26% compared to 12%). POAG patients also tended to have a higher cardiovascular risk than controls. A total of 63% of POAG patients and 55% of controls had a high or very high cardiovascular risk.

The authors found that patients with POAG do have a greater cardiovascular risk than those who do not have glaucoma.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
© 2025 MJH Life Sciences

All rights reserved.